28.96

0.52% -0.15

Handel nachbörslich: 28.96

Guardant Health Inc (GH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt GH? Forum Prognose

Schlusskurs vom Vortag:

$29.11

Offen:

$29.15

24-Stunden-Volumen:

2.37M

Relative Volume:

1.15

Marktkapitalisierung:

$3.58B

Einnahmen:

$643.81M

Nettoeinkommen (Verlust:

$-490.76M

KGV:

-7.133

EPS:

-4.06

Netto-Cashflow:

$-299.27M

1W Leistung:

-1.36%

1M Leistung:

+35.45%

6M Leistung:

+14.20%

1J Leistung:

+24.40%

1-Tages-Spanne:

$28.69

$29.74

1-Wochen-Bereich:

$28.69

$32.26

52-Wochen-Spanne:

$15.81

$37.04

Guardant Health Inc Stock (GH) Company Profile

Firmenname

Guardant Health Inc

Sektor

Healthcare (1196)

Branche

Diagnostics & Research (56)

Telefon

855-698-8887

Adresse

3100 HANOVER STREET, PALO ALTO

Mitarbeiter

1,779

Twitter

@guardanthealth

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

GH's Discussions on Twitter

Vergleichen Sie GH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GH	28.96	3.58B	643.81M	-490.76M	-299.27M	-4.06
TMO	501.29	192.46B	42.37B	6.14B	7.78B	15.26
DHR	230.06	166.23B	23.74B	3.89B	4.98B	7.93
A	126.92	36.47B	6.50B	1.41B	1.42B	3.82
IQV	191.04	34.67B	15.32B	1.41B	1.96B	5.95
IDXX	419.83	34.38B	3.84B	866.24M	792.60M	9.80

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-14	Eingeleitet	Guggenheim	Neutral
2023-12-13	Eingeleitet	Wolfe Research	Peer Perform
2023-11-13	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-09-28	Eingeleitet	Bernstein	Outperform
2023-09-27	Hochstufung	Piper Sandler	Neutral → Overweight
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-05-26	Hochstufung	Citigroup	Neutral → Buy
2023-05-05	Eingeleitet	UBS	Buy
2023-03-09	Herabstufung	Citigroup	Buy → Neutral
2023-01-05	Eingeleitet	Scotiabank	Sector Outperform
2022-11-01	Herabstufung	Piper Sandler	Overweight → Neutral
2022-10-19	Eingeleitet	Craig Hallum	Buy
2022-10-06	Eingeleitet	Stephens	Overweight
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-06-03	Eingeleitet	Piper Sandler	Overweight
2022-04-28	Fortgesetzt	BTIG Research	Buy
2022-02-24	Bestätigt	Canaccord Genuity	Buy
2022-02-24	Bestätigt	Citigroup	Buy
2022-02-24	Bestätigt	Cowen	Outperform
2022-02-24	Bestätigt	Morgan Stanley	Overweight
2022-02-24	Bestätigt	SVB Leerink	Outperform
2022-02-24	Bestätigt	Stifel	Buy
2022-02-24	Bestätigt	Wells Fargo	Overweight
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-06-15	Eingeleitet	Raymond James	Mkt Perform
2021-06-03	Eingeleitet	Goldman	Buy
2021-05-25	Eingeleitet	Wells Fargo	Overweight
2021-01-11	Eingeleitet	Stifel	Buy
2020-09-09	Eingeleitet	Morgan Stanley	Overweight
2020-06-12	Eingeleitet	BTIG Research	Buy
2020-02-21	Eingeleitet	Guggenheim	Buy
2020-01-07	Eingeleitet	Citigroup	Buy
2019-08-07	Bestätigt	Canaccord Genuity	Buy
2019-04-16	Eingeleitet	Canaccord Genuity	Buy
2019-04-10	Hochstufung	BofA/Merrill	Neutral → Buy
2019-02-28	Bestätigt	BofA/Merrill	Neutral
2018-10-29	Eingeleitet	BofA/Merrill	Neutral
2018-10-29	Eingeleitet	JP Morgan	Overweight
2018-10-29	Eingeleitet	William Blair	Outperform

Alle ansehen

Guardant Health Inc Aktie (GH) Neueste Nachrichten

Nov 17, 2024

Sumitomo Mitsui Trust Group Inc. Boosts Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Nov 17, 2024

Nov 16, 2024

Guardant Health (FRA:5GH) Total Inventories : €65.1 Mil (As of Sep. 2024) - GuruFocus.com

Nov 16, 2024

Nov 15, 2024

Natera Exec Calls Guardant's Cancer Test Claims 'Dangerous' - Law360

Nov 15, 2024

Nov 14, 2024

Insider Selling: Director Meghan Joyce Sells Shares of Guardant Health Inc (GH) - GuruFocus.com

Nov 14, 2024

Guardant Health director Ian Clark sells shares worth $244,929 - Investing.com

Nov 14, 2024

Nov 13, 2024

CADIAN CAPITAL MANAGEMENT, LP's Strategic Acquisition in Guardan - GuruFocus.com

Nov 13, 2024

Guardant Atty Accuses Natera CEO Of Dishonesty At Trial - Law360

Nov 13, 2024

Guardant Health Awards 233K RSUs, Stock Options to New Employees in Incentive Plan | GH Stock News - StockTitan

Nov 13, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 13, 2024

Multi-cancer Early Detection Market Next Big Thing| Major Giants Exact Sciences, AnchorDx, Guardant Health - openPR

Nov 09, 2024

Nov 08, 2024

Wellington Management Group LLP Bolsters Stake in Guardant Healt - GuruFocus.com

Nov 08, 2024

Guardant Health, Inc. (NASDAQ:GH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 36% Higher - Simply Wall St

Nov 08, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Bought by ARK Investment Management LLC - MarketBeat

Nov 08, 2024

Guardant Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 08, 2024

Why Guardant Health Stock Blasted 13% Higher on Thursday - MSN

Nov 08, 2024

Nov 07, 2024

Ex-Natera VP Defends Ad Campaign Against Rival Guardant - Law360

Nov 07, 2024

Guardant Health (GH) Stock Surges on Strong Q3 Earnings - GuruFocus.com

Nov 07, 2024

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop - Yahoo! Voices

Nov 07, 2024

Leerink stays bullish on Guardant Health stock, citing robust growth prospects - Investing.com Canada

Nov 07, 2024

JPMorgan Chase & Co. Raises Guardant Health (NASDAQ:GH) Price Target to $50.00 - MarketBeat

Nov 07, 2024

Guardant Health (NASDAQ:GH) Shares Gap Up Following Analyst Upgrade - MarketBeat

Nov 07, 2024

Guardant Health (NASDAQ:GH) Price Target Raised to $36.00 at The Goldman Sachs Group - MarketBeat

Nov 07, 2024